Ian M. Ahearn

Ian M. Ahearn

Auto-generated profile, based on publicly available information

Ian M. Ahearn

The Ronald O Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2011 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
IAIan M. Ahearn
Ian M. Ahearn
KHKevin Haigis
Kevin Haigis
DBDafna Bar-Sagi
Dafna Bar-Sagi
MPMark R. Philips
Mark R. Philips

1 February 2006 in Molecular Cell
Verified
Journal Article
Closed access
TBTrever G. Bivona
Trever G. Bivona
SQSteven E. Quatela
Steven E. Quatela
BBBrian O. Bodemann
Brian O. Bodemann
IAIan M. Ahearn
Ian M. Ahearn
MSMichael J. Soskis
Michael J. Soskis
MPMark R. Philips
Mark R. Philips

29 June 2003 in Nature
Verified
Journal Article
Closed access
PDF file
TBTrever G. Bivona
Trever G. Bivona
Ignacio Perez De CastroIgnacio Perez De Castro
Ignacio Perez De Castro
IAIan M. Ahearn
Ian M. Ahearn
TGTheresa M. Grana
Theresa M. Grana
VCVi K. Chiu
Vi K. Chiu
MPMark R. Philips
Mark R. Philips

11 December 2019 in Nature
Verified
Journal Article
Closed access
PDF file
CACaroline R. Amendola
Caroline R. Amendola
JMJames P. Mahaffey
James P. Mahaffey
SPSeth Parker
Seth Parker
IAIan M. Ahearn
Ian M. Ahearn
WCWei-Ching Chen
Wei-Ching Chen
MPMark R. Philips
Mark R. Philips

23 June 2011 in ACS Nano
Verified
Journal Article
Open access
CVCarlos H. Villa
Carlos H. Villa
TDTao Dao
Tao Dao
IAIan Ahearn
Ian Ahearn
NFNicole Fehrenbacher
Nicole Fehrenbacher
ECEmily Casey
Emily Casey
DSDavid A. Scheinberg
David A. Scheinberg
We studied the feasibility of using single-wall carbon nanotubes (SWNTs) as antigen carriers to improve immune responses to peptides that are weak immunogens, a characteristic typical of human tumor antigens. Binding and presentation of peptide antigens by the MHC molecules of antigen presenting cells (APCs) is essential to mounting an effective immune response. The Wilm’s tumor protein (WT1) is upregulated in many human leukemias and cancers and several vaccines directed at this protein are in human clinical trials. WT1 peptide 427 induces human CD4 T cell responses in the context of multiple human HLA-DR.B1 molecules, but the peptide has a poor binding affinity to BALB/c mouse MHC class II molecules. We used novel, spectrally quantifiable chemical approaches to covalently append large numbers of peptide ligands (0.4 mmol/g) onto solubilized SWNT scaffolds. Peptide-SWNT constructs were rapidly internalized into professional APCs (dendritic cells and macrophages) within minutes in vitro, in a dose dependent manner. Immunization of BALB/c mice with the SWNT–peptide constructs mixed with immunological adjuvant induced specific IgG responses against the peptide, while the peptide alone or peptide mixed with the adjuvant did not induce such a response. The conjugation of the peptide to SWNT did not enhance the peptide-specific CD4 T cell response in human and mouse cells, in vitro. The solubilized SWNTs alone were nontoxic in vitro, and we did not detect antibody responses to SWNT in vivo. These results demonstrated that SWNTs are able to serve as antigen carriers for delivery into APCs to induce humoral immune responses against weak tumor antigens.

28 April 2008 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
DMDavid Michaelson
David Michaelson
WAWasif Abidi
Wasif Abidi
DGDaniele Guardavaccaro
Daniele Guardavaccaro
MZMo Zhou
Mo Zhou
IAIan Ahearn
Ian Ahearn
MPMark R. Philips
Mark R. Philips
Rac1 regulates a wide variety of cellular processes. The polybasic region of the Rac1 C terminus functions both as a plasma membrane–targeting motif and a nuclear localization sequence (NLS). We show that a triproline N-terminal to the polybasic region contributes to the NLS, which is cryptic in the sense that it is strongly inhibited by geranylgeranylation of the adjacent cysteine. Subcellular fractionation demonstrated endogenous Rac1 in the nucleus and Triton X-114 partition revealed that this pool is prenylated. Cell cycle–blocking agents, synchronization of cells stably expressing low levels of GFP-Rac1, and time-lapse microscopy of asynchronous cells revealed Rac1 accumulation in the nucleus in late G2 and exclusion in early G1. Although constitutively active Rac1 restricted to the cytoplasm inhibited cell division, activated Rac1 expressed constitutively in the nucleus increased the mitotic rate. These results show that Rac1 cycles in and out of the nucleus during the cell cycle and thereby plays a role in promoting cell division.